Doctors Without Borders (MSF) has called for a drastic reduction in the price of a key medication used to prevent HIV infection, as the International AIDS Conference begins in Rio de Janeiro on Sunday.
"No one should be excluded from HIV prevention simply because a medicine is being kept artificially expensive," said Melissa Scharwey, a global health expert at MSF.
Advertisement AdvertisementAccording to MSF, US pharmaceutical company Gilead charges $28,000 for a year's supply of lenacapavir, which requires two injections.
At the same time, global efforts to combat HIV are under increasing pressure because of a sharp decline in international health funding.
The conference in Rio de Janeiro, organized by the International Aids Society, runs until Friday.
Powered by Yahoo Scout. Yahoo is using AI to generate key points from this article. This means the info may not always match what’s in the article. Reporting mistakes helps us improve the experience.
Key takeaways Powered by Yahoo Scout. Yahoo is using AI to generate key points from this article. This means the info may not always match what’s in the article. Reporting mistakes helps us improve the experience.
Doctors Without Borders (MSF) has called for a drastic reduction in the price of a key medication used to prevent HIV infection, as the International AIDS Conference begins in Rio de Janeiro on Sunday.
"No one should be excluded from HIV prevention simply because a medicine is being kept artificially expensive," said Melissa Scharwey, a global health expert at MSF.
The organization is demanding a price of around $40 per person per year for the drug lenacapavir and for the widespread production of lower-cost generic versions.
Advertisement Advertisement
According to MSF, US pharmaceutical company Gilead charges $28,000 for a year's supply of lenacapavir, which requires two injections.
This price applies to the treatment of people already living with HIV in the United States, not to its use as a preventive medication. MSF argues that this is unaffordable for health care systems in low- and middle-income countries.
Two injections instead of daily pills
For HIV prevention, lenacapavir is administered twice a year by injection, offering an alternative to the daily tablets used for pre-exposure prophylaxis (PrEP).
According to the German AIDS Action Alliance, around 1.2 million people become newly infected with HIV each year worldwide, while approximately 570,000 people die from AIDS-related illnesses.
Advertisement Advertisement
For the first time, more than half of all new HIV infections now occur outside sub-Saharan Africa, according to the organization.
At the same time, global efforts to combat HIV are under increasing pressure because of a sharp decline in international health funding.
The conference in Rio de Janeiro, organized by the International Aids Society, runs until Friday.
